Fry, AM, et al.
Seasonal trends of human parainfluenza viral infections: United States, 1990–2004. Clinical Infectious Diseases
2006; 43: 1016–1022.
Hall, CB. Respiratory syncytial virus and parainfluenza virus. New England Journal of Medicine
2001; 344: 1917–1928.
Schmidt, AC, et al.
Progress in the development of human parainfluenza virus vaccines. Expert Review of Respiratory Medicine
2011; 5: 515–526.
Glezen, WP, et al.
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. Journal of Infectious Diseases
1984; 150: 851–857.
Henrickson, KJ. Parainfluenza viruses. Clinical Microbiology Reviews
2003; 16: 242–264.
Counihan, ME, et al.
Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatric Infectious Disease Journal
2001; 20: 646–653.
Iwane, MK, et al.
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics
2004; 113: 1758–1764.
Reed, G, et al.
Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. Journal of Infectious Diseases
1997; 175: 807–813.
Senchi, K. Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3. Frontiers in Microbiology
2013; 4: 346.
Muller-Pebody, B, et al.
Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiology and Infection
2002; 129: 99–106.
Weinberg, GA, et al.
Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. Journal of Pediatrics
2009; 154: 694–699.
Liu, WK, et al.
Epidemiology and clinical presentation of the four human parainfluenza virus types. BMC Infectious Diseases
2013; 13: 28.
Marx, A, et al.
Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection. Clinical Infectious Diseases
1999; 29: 134–140.
Glasgow, KW, Tamblyn, SE, Blair, G. A respiratory outbreak due to parainfluenza virus type 3 in a home for the aged – Ontario. Canada Communicable Disease Report
1995; 21: 57–61.
Karron, RA, et al.
Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. Journal of Infectious Diseases
1993; 167: 1441–1445.
Wendt, CH, et al.
Parainfluenza virus respiratory infection after bone marrow transplantation. New England Journal of Medicine
1992; 326: 921–926.
Zambon, MC, et al.
Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit. Journal of Clinical Microbiology
1998; 36: 2289–2293.
Centers for Disease Control and Prevention. Parainfluenza outbreaks in extended-care facilities – United States. Morbidity and Mortality Weekly Report
1978; 27: 475.
Centre PHLSDS. Parainfluenza infections in the elderly 1976–82. British Medical Journal (Clinical Research Edition)
1983; 287: 1619.
Hohenthal, U, et al.
Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplantation
2001; 27: 295–300.
Laurichesse, H, et al.
Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975–1997. European Journal of Epidemiology
1999; 15: 475–484.
RCGP Research & Surveillance Centre. Weekly Returns Service, Annual Report 2011.
Grant, AD, Eke, B. Application of information technology to the laboratory reporting of communicable disease in England and Wales. Communicable Disease Report. CDR Review
1993; 3: R75–R78.
Zhao, H, et al.
A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012. Eurosurveillance
Shi, W, et al.
Prevalence of human parainfluenza virus in patients with acute respiratory tract infections in Beijing, 2011–2014. Influenza and Other Respiratory Viruses
2015; 9: 305–307.
Mizuta, K, et al.
Epidemiology of parainfluenza virus types 1, 2 and 3 infections based on virus isolation between 2002 and 2011 in Yamagata, Japan. Microbiology and Immunology
2012; 56: 855–858.
De Silva, LM, Cloonan, MJ. Brief report: parainfluenza virus type 3 infections: findings in Sydney and some observations on variations in seasonality world-wide. Journal of Medical Virology
1991; 35: 19–21.
Easton, AJ, Eglin, RP. Epidemiology of parainfluenza virus type 3 in England and Wales over a ten-year period. Epidemiology and Infection
1989; 102: 531–535.
Glezen, P, Denny, FW. Epidemiology of acute lower respiratory disease in children. New England Journal of Medicine
1973; 288: 498–505.
Glezen, WP, et al.
Epidemiologic patterns of acute lower respiratory disease of children in a pediatric practice. Journal of Paediatrics
1971; 78: 397–406.
Marx, A, et al.
Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. Journal of Infectious Diseases
1997; 176: 1423–1427.
Abedi, GR, et al.
Estimates of parainfluenza virus-associated hospitalizations and cost among children aged less than 5 years in the United States, 1998–2010. Journal of the Pediatric Infectious Diseases Society. Published online: 2 June 2014. doi: 10.1093/jpids/piu047.
Knott, AM, Long, CE, Hall, CB. Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatric Infectious Diseases Journal
1994; 13: 269–273.
Lau, SK, et al.
Human parainfluenza virus 4 outbreak and the role of diagnostic tests. Journal of Clinical Microbiology
2005; 43: 4515–4521.
Jalal, H, et al.
Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. Journal of Clinical Microbiology
2007; 45: 1690–1696.